Back to Search
Start Over
Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
- Source :
- Liver International, Repositório Científico de Acesso Aberto de Portugal, Repositório Científico de Acesso Aberto de Portugal (RCAAP), instacron:RCAAP
- Publication Year :
- 2019
- Publisher :
- John Wiley and Sons Inc., 2019.
-
Abstract
- Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence‐gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints.
- Subjects :
- Economic growth
IMPACT
HISTORICAL EPIDEMIOLOGY
Review Article
Health Services Accessibility
Global Burden of Disease
Organizational Case Studies
0302 clinical medicine
disease elimination
GLOBAL EPIDEMIOLOGY
Sustainable Development
Hepatitis B
Investment (macroeconomics)
Hepatitis C
investment case
organizational case studies
030220 oncology & carcinogenesis
HCV
Health Resources
030211 gastroenterology & hepatology
Public Health
Viral hepatitis
medicine.medical_specialty
Investment case
Developing country
Reviews
World Health Organization
Disease elimination
Developing countries
03 medical and health sciences
PEOPLE
medicine
Humans
Hepatitis
Sustainable development
Hepatology
Public health
SELECT COUNTRIES
HIV
developing countries
medicine.disease
Organizational case studies
Models, Organizational
Business
hepatitis B
INJECTING DRUG-USE
hepatitis C
C VIRUS-INFECTION
SUBSTITUTION THERAPY
Subjects
Details
- Language :
- English
- ISSN :
- 14783231 and 14783223
- Volume :
- 39
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Liver International
- Accession number :
- edsair.doi.dedup.....3c07cad122cd70c5067161cf3d632448